Omega buys Allergopharma's allergy IVD assets; outlines sales growth strategy
This article was originally published in Clinica
Executive Summary
Omega Diagnostics has conditionally agreed to acquire the IVD division of German allergy products developer Allergopharma Joachim Ganzer. The move paves the way for Omega's entry into the $3bn global allergy testing market, of which Swedish company Phadia is the leader.